Previous close | 27.11 |
Open | 26.91 |
Bid | 26.62 x 100 |
Ask | N/A x N/A |
Day's range | 26.57 - 26.91 |
52-week range | 24.51 - 27.20 |
Volume | |
Avg. volume | 77,013 |
Net assets | 9.97M |
NAV | 27.07 |
PE ratio (TTM) | N/A |
Yield | N/A |
YTD daily total return | N/A |
Beta (5Y monthly) | 0.00 |
Expense ratio (net) | 0.59% |
Inception date | 2024-05-20 |
Roundhill Investments, an ETF sponsor focused on innovative financial products, is pleased to announce the launch of the Roundhill GLP-1 & Weight Loss ETF (OZEM), which began trading on Nasdaq today. OZEM is the world's first ETF focused exclusively on the rapidly growing sector of GLP-1 receptor agonists and other weight management drugs.